Why Doesn't Steroid Treatment Improve LHON Vision Loss?
At a Glance
Steroids treat inflammation, but LHON causes optic nerve damage through an inherited problem with cell energy rather than inflammation. They are not a proven treatment for LHON vision loss, and persistent or worsening vision after steroids needs urgent reassessment and genetic testing.
In this answer
3 sections
If you were given intravenous (IV) steroids for suspected optic neuritis but your vision did not improve, it can be a frightening experience. While a lack of response to steroids does not prove you have Leber Hereditary Optic Neuropathy (LHON), a failure to recover or continued worsening of your vision is an important clinical “red flag” that should prompt doctors to reassess your diagnosis [1].
Steroids are designed to treat inflammation. LHON, however, is a genetic condition causing an energy failure in the optic nerve cells [2]. Because steroids cannot fix this underlying mitochondrial problem, they are not proven to improve vision in LHON [2] [3]. Please do not start, stop, or change prescribed steroid treatments without consulting your clinician, as sudden or progressive vision loss requires urgent and ongoing medical evaluation.
Two Different Mechanisms of Vision Loss
When a person experiences sudden central vision loss, doctors often first suspect optic neuritis. This is an inflammation of the optic nerve that is often—but not always—accompanied by pain when moving the eyes [4]. It typically involves the body’s immune system mistakenly attacking the nerve. Because IV steroids are powerful anti-inflammatory drugs, they are often given to speed up the recovery process, though they do not guarantee an immediate visual improvement or change the final visual outcome [4] [5].
In contrast, LHON is a genetic mitochondrial disease [6]. Mitochondria are the “powerhouses” of your cells. In LHON, a genetic mutation prevents the mitochondria in the optic nerve cells (called retinal ganglion cells, which carry visual signals from the eye to the brain) from producing enough ATP—the energy the cells need to survive [2] [7]. At the same time, this defect causes a buildup of harmful byproducts called reactive oxygen species [2] [8].
This combination of severe energy shortage and toxic buildup damages the optic nerve cells, causing a painless loss of central vision [7] [4]. Because the primary problem in LHON is mitochondrial energy failure rather than inflammation, anti-inflammatory medications like steroids are not known to improve the course of LHON [2] [3]. In documented cases where LHON was initially thought to be optic neuritis, vision continued to worsen despite steroid therapy and other immune treatments [9] [3].
When to Reassess the Diagnosis
It is very common for LHON to be initially misdiagnosed as optic neuritis because both cause rapid loss of central vision [3] [9]. In typical optic neuritis, visual recovery may take days or weeks to begin. However, if your vision completely fails to recover over time or progressively worsens after steroids, it warrants an urgent reassessment by a neuro-ophthalmologist [1].
Doctors will look for specific clinical clues that point toward LHON, including:
- Vision loss that is completely painless [10].
- Vision loss that starts in one eye and affects the second eye sequentially (often weeks or months later), though it can sometimes happen in both eyes simultaneously [11].
- A family history of vision loss on the mother’s side of the family [12]. However, many people with LHON have no known family history, so a lack of affected relatives does not rule it out [10].
Remember, these features alone cannot diagnose LHON. Sudden or progressive vision loss could also be caused by other inflammatory, infectious, compressive, toxic, or ischemic (blood flow) problems, requiring professional medical care to identify the true cause.
Next Steps for a Correct Diagnosis
If your doctor suspects LHON, diagnosis involves a combination of eye exams, imaging (like MRI or OCT scans to view the optic nerve), and genetic testing.
A blood or saliva test will typically first check for the three most common mitochondrial DNA variants responsible for LHON (specifically m.11778G>A, m.14484T>C, and m.3460G>A) [12] [13]. Importantly, a negative result on this limited panel does not entirely rule out LHON; rarer genetic variants exist, and broader genetic sequencing or specialist interpretation may be required [12] [13].
Confirming the diagnosis with genetic testing is vital because it can prevent prolonged use of ineffective immune treatments for an incorrect diagnosis [1]. It also allows you to seek genetic counseling—which helps you understand testing for maternal relatives—and discuss potential therapies (such as idebenone) or clinical trials targeting mitochondrial function. Be aware that the eligibility and regulatory approval for these therapies vary by country, and they do not guarantee visual recovery [14] [15].
While awaiting answers, it is often recommended to avoid smoking and heavy alcohol use, as these can put further stress on your mitochondria [16]. Always discuss these lifestyle changes and any current medications with your healthcare team.
Common questions in this guide
Why don't steroids usually improve vision in LHON?
Does not improving after steroid treatment mean that I have LHON?
What symptoms make LHON more likely than optic neuritis?
How is LHON confirmed if steroids do not work?
What should I do if my vision is still worsening after steroids?
What treatments may be available if LHON is confirmed?
Related questions
Show more
Get notified when new evidence is published on Leber hereditary optic neuropathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Mitochondrial Mutations in Multiple Sclerosis Patients with Atypical Optic Neuropathy.
Beckmann Y, Uzunköprü C, Subaşıoğlu A
Multiple sclerosis and related disorders 2021; (55()):103166 doi:10.1016/j.msard.2021.103166.
PMID: 34333271 - 2
Leber Hereditary Optic Neuropathy-Light at the End of the Tunnel?
Kim US, Jurkute N, Yu-Wai-Man P
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; (7(4)):242-245 doi:10.22608/APO.2018293.
PMID: 30008192 - 3
Leber Hereditary Optic Neuropathy With Magnetic Resonance Imaging Findings Suggestive of Optic Perineuritis and Optic Neuritis: A Diagnostic Challenge.
Horiuchi K, Nakamura S, Yamada K
Cureus 2025; (17(3)):e80439 doi:10.7759/cureus.80439.
PMID: 40225540 - 4
The Diagnosis and Treatment of Optic Neuritis.
Wilhelm H, Schabet M
Deutsches Arzteblatt international 2015; (112(37)):616-25; quiz 626.
PMID: 26396053 - 5
Updates and Controversies in the Management of Acute Optic Neuritis.
Meltzer E, Prasad S
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; (7(4)):251-256 doi:10.22608/APO.2018108.
PMID: 29667789 - 6
[Considering Leber´s hereditary optic neuropathy].
Priglinger C
MMW Fortschritte der Medizin 2023; (165(Suppl 1)):18-19 doi:10.1007/s15006-023-2311-7.
PMID: 36849766 - 7
A neurodegenerative perspective on mitochondrial optic neuropathies.
Yu-Wai-Man P, Votruba M, Burté F, et al.
Acta neuropathologica 2016; (132(6)):789-806 doi:10.1007/s00401-016-1625-2.
PMID: 27696015 - 8
Pathophysiology of Conversion to Symptomatic Leber Hereditary Optic Neuropathy and Therapeutic Implications: a Review.
Mejia-Vergara AJ, Seleme N, Sadun AA, Karanjia R
Current neurology and neuroscience reports 2020; (20(5)):11 doi:10.1007/s11910-020-01032-8.
PMID: 32296973 - 9
Central Serous Chorioretinopathy Associated with Corticosteroid Use in a Patient with Leber Hereditary Optic Neuropathy: A Case Report.
Zoric L, Petrovic A, Milutinovic V
Medicina (Kaunas, Lithuania) 2024; (61(1)) doi:10.3390/medicina61010007.
PMID: 39858989 - 10
Leber hereditary optic neuropathy presenting as bilateral visual loss and white matter disease.
Algahtani H, Shirah B, Abdulkareem AA, et al.
Bioinformation 2023; (19(3)):226-229 doi:10.6026/97320630019226.
PMID: 37808372 - 11
[Leber hereditary optic neuropathy: clinical picture and initial workup data].
Clermont CV
Journal francais d'ophtalmologie 2022; (45(8S1)):S3-S8 doi:10.1016/S0181-5512(22)00444-2.
PMID: 36529475 - 12
Recognizing Leber's Hereditary Optic Neuropathy to avoid delayed diagnosis and misdiagnosis.
La Morgia C, Cascavilla ML, De Negri AM, et al.
Frontiers in neurology 2024; (15()):1466275 doi:10.3389/fneur.2024.1466275.
PMID: 39364415 - 13
Clinical Reasoning: A 31-Year-Old Man With Sequential Vision Loss.
Fortes B, Chen JJ, Bhatti MT
Neurology 2022; (98(4)):163-169 doi:10.1212/WNL.0000000000013084.
PMID: 34799463 - 14
Idebenone: A Review in Leber's Hereditary Optic Neuropathy.
Lyseng-Williamson KA
Drugs 2016; (76(7)):805-13 doi:10.1007/s40265-016-0574-3.
PMID: 27071925 - 15
[Medical treatments in Leber's hereditary optic neuropathy].
Hage R
Journal francais d'ophtalmologie 2022; (45(8S1)):S24-S31 doi:10.1016/S0181-5512(22)00447-8.
PMID: 36529474 - 16
["Triple-hit" pathogenic mechanism of Leber hereditary optic neuropathy].
Wang K, Li S, Zhang Y, Guan M
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2026; (55(7)):683-690 doi:10.3724/zdxbyxb-2025-0868.
PMID: 42260285
This page explains why steroids are not a proven treatment for LHON for informational purposes only and does not constitute medical advice. Sudden or worsening vision loss requires urgent evaluation by a clinician, and prescribed steroids should not be changed without medical guidance.